ARVC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

390 results for “ARVC”

Trials

View all 284 →

IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy

1 participants · First posted Feb 23, 2024

FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))

15 participants · First posted May 4, 2026

Arrhythmogenic Activity During Exercise in ARVC Patients

120 participants · First posted Sep 15, 2023

Drugs

View all 66 →

LX-2021

ARAC

ADVC-001

Organizations

ARC Funds Ltd

United States

ARC Medical Devices Inc

Canada

Red-D-Arc Limited

Canada

News

View all 36 →

FDA Grants RMAT Designation to Tenaya's TN-401 Gene Therapy for PKP2-Associated ARVC

AMO Pharma Launches Largest-Ever Clinical Trial for Rare Heart Condition ARVC with GSK3β Inhibitor AMO-02

Tenaya Therapeutics Doses First Patient in Cardiac Gene Therapy Trial for ARVC

Page 1 of 39